Article: Inventiva completes a capital increase of €15 m subscribed by existing shareholders

Article - Media, Publications

Inventiva completes a capital increase of €15 m subscribed by existing shareholders

Yahoo Finance, 07 February 2020

Daix (France), February 7, 2020 – Inventiva (IVA.NX), a clinical-stage biopharmaceutical company developing oral small molecule therapies for the treatment of diseases in the areas of fibrosis, lysosomal storage disorders and oncology, today announced the successful completion of a capital increase of €15 million subscribed by some of its current key shareholders, BVF Partners L.P., NEA, Novo Holdings A/S and Sofinnova Partners. The capital increase was executed at the closing price of February 6, 2020 without discount.

Read Full Article

THE DOLLAR HAS NO INTRINSIC VALUE : DO YOUR ASSETS?